402 Dual Inhibition of the MEK and the PI3K-Akt-mTOR Pathways Using GSK1120212 (or UO126) and Everolimus Overcomes Resistance to MEK Inhibitors Used as Single Agents in Pancreatic Cancer Cells

2012 ◽  
Vol 48 ◽  
pp. 122
Author(s):  
C. Neuzillet ◽  
M. Serova ◽  
A. Raballand ◽  
L. Astorgues-Xerri ◽  
M.E. Riveiro ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Cells ◽  
Mek Inhibitors ◽  
Pancreatic Cancer Cells ◽  
Dual Inhibition

scholarly journals Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and HDAC

Pancreatology ◽  
2020 ◽  
Vol 20 (3) ◽  
pp. 558-561 ◽  
Author(s):  
Kateryna Nesteruk ◽  
Ron Smits ◽  
Marco Bruno ◽  
Maikel P. Peppelenbosch ◽  
Gwenny M. Fuhler
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Cells ◽  
Pancreatic Cancer Cells ◽  
Dual Inhibition

scholarly journals Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells

2011 ◽  
Vol 17 (9) ◽  
pp. 2744-2756 ◽  
Author(s):  
Caroline H. Diep ◽  
Ruben M. Munoz ◽  
Ashish Choudhary ◽  
Daniel D. Von Hoff ◽  
Haiyong Han
Keyword(s):  
Pancreatic Cancer ◽  
Synergistic Effect ◽  
Cancer Cells ◽  
Human Pancreatic Cancer ◽  
Wild Type ◽  
Mek Inhibitors ◽  
Pancreatic Cancer Cells

ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S

2022 ◽  
pp. 109811
Author(s):  
Lei Yuan ◽  
Juanping Zhao ◽  
Songkun Zhao ◽  
Tianyi Dong ◽  
Ruitong Dong ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Cells ◽  
Cathepsin L ◽  
Cathepsin S ◽  
Pancreatic Cancer Cells ◽  
Dual Inhibition
Sign in / Sign up

Export Citation Format

Share Document